Capital International Investors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,066,164
| Closed | -$326M | – | 433 |
|
|
2022
Q3 | $326M | Sell |
11,066,164
-8,021,525
| -42% | -$236M | 0.1% | 194 |
|
|
2022
Q2 | $831M | Sell |
19,087,689
-12,553
| -0.1% | -$546K | 0.23% | 114 |
|
|
2022
Q1 | $832M | Sell |
19,100,242
-17,984
| -0.1% | -$783K | 0.19% | 129 |
|
|
2021
Q4 | $843M | Sell |
19,118,226
-3,541,985
| -16% | -$156M | 0.18% | 129 |
|
|
2021
Q3 | $866M | Sell |
22,660,211
-16,534
| -0.1% | -$632K | 0.2% | 121 |
|
|
2021
Q2 | $903M | Buy |
22,676,745
+2,787,034
| +14% | +$111M | 0.21% | 111 |
|
|
2021
Q1 | $710M | Buy |
19,889,711
+2,271,163
| +13% | +$81.1M | 0.18% | 130 |
|
|
2020
Q4 | $648M | Buy |
17,618,548
+1,113,398
| +7% | +$41M | 0.18% | 130 |
|
|
2020
Q3 | $621M | Sell |
16,505,150
-2,323,493
| -12% | -$87.4M | 0.19% | 123 |
|
|
2020
Q2 | $768M | Buy |
18,828,643
+4,064,539
| +28% | +$166M | 0.25% | 105 |
|
|
2020
Q1 | $559M | Buy |
14,764,104
+8,858,438
| +150% | +$336M | 0.23% | 107 |
|
|
2019
Q4 | $278M | Buy |
5,905,666
+6,143
| +0.1% | +$289K | 0.09% | 164 |
|
|
2019
Q3 | $252M | Buy |
5,899,523
+781,917
| +15% | +$33.4M | 0.1% | 166 |
|
|
2019
Q2 | $205M | Buy |
5,117,606
+215,174
| +4% | +$8.61M | 0.08% | 190 |
|
|
2019
Q1 | $205M | Buy |
4,902,432
+3,188,332
| +186% | +$133M | 0.09% | 181 |
|
|
2018
Q4 | $65.5M | Buy |
+1,714,100
| New | +$65.5M | 0.03% | 232 |
|